1Wolf SF, Temple PA, Robayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 1991,146(9) :3074-3081.
2Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor(NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med,1989,170(3) :827-844.
3Lieberman MD, Sigal RK, Williams NN, et al. Natural killer cell stimulatory factor(NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines. J Surg Res, 1991,50(4) :410-415.
4Gately MK. Interleukin-12: potential clinical application in the treatment of chronic viral hepatitis. J Viral Hepatitis, 1997,4(Suppl 1): 33-39.
5Cassatella MA, Meda I, Gasperini S, et al. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol, 1995,25(1): 1-5.
6Brunda MJ. Interleukin-12. J Leukoc Biol, 1994,55(2):280-288.
7Hasko G, Szabo C. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of Th1/Th2 response. Br J Pharm, 1999, 127(6): 1295-1304.
8Zhou P, Sieve MC, Bennett J, et al. IL-12 prevents mortality in mice infected with histoplasma capsulatum through induction of IFN-gamma. J Immunol, 1995,155(2) :785-795.
9Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science, 1994,263(5153):1612-1615.
10Cenci E, Romani L, Mencacci A, et al. IL-4 and IL-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans.Eur J Immunol, 1993,23(5): 1034-1038.
